Ward, K. N., N. J. Bryant, N. J. Andrews, J. S. Bowley, A. Ohrling, C. M. Verity, E. M. Ross, and E. Miller. 2007. Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Pediatrics 120(2):314-321.
Watson, R. G., and H. W. Scherp. 1958. The specific hapten of group C (group-II alpha) meningococcus. I. Preparation and immunological behavior. Journal of Immunology 81(4):331-336.
Yergeau, A., L. Alain, R. Pless, and Y. Robert. 1996. Adverse events temporally associated with meningococcal vaccines. Canadian Medical Association Journal 154(4):503-507.
The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
"11 Meningococcal Vaccine."
Adverse Effects of Vaccines: Evidence and Causality.
Washington, DC: The National Academies Press, 2012.
Please select a format: